We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
The potential of native microalgae consortia to remove pharmaceutical compounds present in treated wastewater
Summary
Researchers assessed the ability of native microalgae consortia to remove pharmaceutical compounds from treated wastewater over a one-year study period. They detected and quantified 19 pharmaceutical compounds across multiple drug classes and found that the microalgae achieved varying removal efficiencies depending on the compound. The study suggests that microalgae-based treatment could complement conventional wastewater processing to reduce pharmaceutical contamination reaching aquatic environments.
Wastewater treatment plants play a key role in the release of pharmaceuticals and other contaminants into the aquatic environment, causing negative effects on the ecosystems of receiving water bodies. This work aimed to assess the removal efficiency of real loads of these contaminants by wastewater-native microalgae consortia acting on treated wastewater previously subjected to secondary treatment. Wastewater sampling and removal efficiency experiments were conducted over 1 year at three different sampling points. Nineteen pharmaceutical compounds of different drug classes (stimulants, anticonvulsants, antidepressants, antibiotics, β-blockers, lipid regulators, and nonsteroidal anti-inflammatory drugs/analgesics), as well as one herbicide/algicide (Diuron) were detected and quantified. Native blooming microalgae consortia were grown in treated wastewaters, and their potential to remove these compounds was quantified. The removal efficiency of these compounds by native microalgae consortia was variable, ranging from almost no removal for Clofibric acid or Ketoprofen to near complete removal for Fluoxetine, Venlafaxine, Atenolol or Diuron. These variations were influenced not only by the molecular nature of the compounds but also by the microbial composition variability of the microalgae consortia, especially among the prokaryotes present. Overall, microalgae consortia successfully removed between 40 % and 83 % of the total detected compounds, preventing a significant part of these from entering the aquatic environment, contributing to enhance treated wastewater quality. Significant biomass growth was observed, reaching dry-weight concentrations up to 2.6 g.L-1, indicative of good capacity of the grown consortia to deal with the toxicity effects of the pollutants. In addition to what is now reported, microalgae treatment also removes other pollutants, such as nutrients, metals or microplastic particles, constituting a versatile tertiary treatment for polishing treated wastewaters. These findings demonstrate the potential of native microalgae consortia-based systems to improve wastewater treatment processes, mitigating the environmental impact of pharmaceutical compounds while producing potentially useful biomass.
Sign in to start a discussion.
More Papers Like This
Advancements in microalgae-mediated technologies for antibiotic removal from wastewater: a review
Researchers reviewed microalgae-based technologies for removing antibiotics from wastewater, examining the mechanisms of removal — including adsorption, biodegradation, photodegradation, and hydrolysis — and how microalgae perform in combination with advanced oxidation and photocatalysis systems, while identifying key operational parameters such as pH, temperature, and light intensity that influence treatment efficiency.
Progress in microalgal mediated bioremediation systems for the removal of antibiotics and pharmaceuticals from wastewater
Researchers reviewed microalgae-based systems for removing antibiotics and pharmaceuticals from wastewater, summarizing bioadsorption, photodegradation, and bioaccumulation mechanisms, and highlighting how integrating microalgal treatment with biofuel or biochemical co-production can improve the economic viability of this approach.
Are native microalgae consortia able to remove microplastics from wastewater effluents?
Researchers investigated whether native microalgae communities found in wastewater could effectively remove microplastics from treatment plant effluent. The study monitored microplastic occurrence across two different types of wastewater treatment plants over one year, characterizing particles by shape, size, and polymer type. Evidence indicates that wastewater-native microalgae consortia show potential as a dual-purpose solution for both microplastic mitigation and biomass production.
Removal of Antibiotics Using an Algae-Algae Consortium (Chlorella protothecoides and Chlorella vulgaris)
Researchers tested a partnership between two species of Chlorella algae for removing antibiotics from wastewater and found it to be an effective and environmentally friendly treatment approach. The algae consortium successfully removed significant amounts of common antibiotics while also absorbing nutrients from the water. The study highlights algae-based treatment as a promising sustainable alternative to conventional methods for addressing pharmaceutical pollution in water systems.
Pharmaceuticals in the Aquatic Environment: A Review on Eco-Toxicology and the Remediation Potential of Algae
This review examines how pharmaceutical drugs end up in water through human activity and the damage they cause to aquatic life. Standard wastewater treatment plants are not designed to remove these drugs effectively, so researchers are exploring the use of algae as a low-cost, natural cleanup method. While not directly about microplastics, this is relevant because microplastics in water can absorb and transport pharmaceutical chemicals, potentially increasing human exposure.